The pharmacological therapy for gastrointestinal (GI) diseases, such as inflammatory bowel diseases, continues to present challenges in targeting efficacy. The need for maximal local drug exposure at the inflamed regions of the GI tract has led research to focus on a disease-targeted drug delivery approach. Smart nanomaterials responsive to the reactive oxygen species (ROS) concentrated in the inflamed areas, can be formulated into nanoplatforms to selectively release the active compounds, avoiding unspecific drug delivery to healthy tissues and limiting systemic absorption. Recent developments of ROS-responsive nanoplatforms include combination with other materials to obtain multi-responsive systems and modifications/derivatization to increase the interactions with biological tissues, cell uptake and targeting. This review describes the applications of ROS-responsive nanosystems for on-demand drug delivery to the GI tract.
K E Y W O R D Sgastrointestinal tract drug delivery, irritable bowel disease, oxidation-responsive materials, stimuli-responsive nanocarriers
Biopolymeric injectable
hydrogels are promising biomaterials
for
myocardial regeneration applications. Besides being biocompatible,
they adjust themselves, perfectly fitting the surrounding tissue.
However, due to their nature, biopolymeric hydrogels usually lack
desirable functionalities, such as antioxidant activity and electrical
conductivity, and in some cases, mechanical performance. Protein nanofibrils
(NFs), such as lysozyme nanofibrils (LNFs), are proteic nanostructures
with excellent mechanical performance and antioxidant activity, which
can work as nanotemplates to produce metallic nanoparticles. Here,
gold nanoparticles (AuNPs) were synthesized in situ in the presence
of LNFs, and the obtained hybrid AuNPs@LNFs were incorporated into
gelatin-hyaluronic acid (HA) hydrogels for myocardial regeneration
applications. The resulting nanocomposite hydrogels showed improved
rheological properties, mechanical resilience, antioxidant activity,
and electrical conductivity, especially for the hydrogels containing
AuNPs@LNFs. The swelling and bioresorbability ratios of these hydrogels
are favorably adjusted at lower pH levels, which correspond to the
ones in inflamed tissues. These improvements were observed while maintaining
important properties, namely, injectability, biocompatibility, and
the ability to release a model drug. Additionally, the presence of
AuNPs allowed the hydrogels to be monitorable through computer tomography.
This work demonstrates that LNFs and AuNPs@LNFs are excellent functional
nanostructures to formulate injectable biopolymeric nanocomposite
hydrogels for myocardial regeneration applications.
During the last 20+ years, research into the biomedical application of nanotechnology has helped in reshaping cancer treatment. The clinical use of several passively targeted nanosystems resulted in improved quality of care for patients. However, the therapeutic efficacy of these systems is not superior to the original drugs. Moreover, despite extensive investigations into actively targeted nanocarriers, numerous barriers still remain before their successful clinical translation, including sufficient bloodstream circulation time and efficient tumor targeting. The combination of synthetic nanomaterials with biological elements (e.g., cells, cell membranes, and macromolecules) is presently the cutting-edge research in cancer nanotechnology. The features provided by the biological moieties render the particles with prolonged bloodstream circulation time and homotopic targeting to the tumor site. Moreover, cancer cell membranes serve as sources of neoantigens, useful in the formulation of nanovaccines. In this chapter, we will discuss the advantages of biohybrid nanosystems in cancer chemotherapy, immunotherapy, and combined therapy, as well as highlight their preparation methods and clinical translatability.
Common pharmacological therapies for gastrointestinal diseases, e.g., inflammatory bowel diseases, irritable bowel syndrome and colon cancer, continue to show challenges in targeting efficacy. Moreover, current conventional oral therapies present different adverse effects associated with systemic exposure. Bertoni et al. summarize innovative approaches to overcoming these drawbacks using disease‐targeted drug delivery systems, including the production and characterization of the nanoplatforms. The smart nanomaterials described respond to increased levels of reactive oxygen species (ROS) concentrated in the inflamed areas, as well as to other more commonly used stimuli, for instance variation of pH value. (DOI: https://doi.org/10.1002/bip.23336)
Apoptosis is the natural programmed cell death process, which is responsible for abnormal cell clearance. However, many cancer cells develop various mechanisms to escape apoptosis through interrupting apoptosome assembly, which is a key step to initiate apoptosis. This promotes tumorigenesis and drug resistance, and thus, poses a great challenge in cancer treatment. Herein, a biomimetic lipid nanocarrier mimicking mitochondrial Cytochrome C (Cyt C) binding is developed. Cardiolipin, the major phospholipid of mitochondrial inner membrane, is introduced as the main component in biomimetic liposomal formulation. With the help of cardiolipin, Cyt C is sufficiently loaded in liposome based on electrostatic and hydrophobic interaction with cardiolipin. Lonidamine (LND) is added in hydrophobic phase of liposome to modulate the metabolic activity within cancer cells and sensitize the cells to Cyt C‐induced apoptosis. The results suggest that LND reduces ATP level and creates favorable environment for Cyt C induced apoptosome assembly, exhibiting higher apoptosis level and anti‐tumor efficacy in vitro and in vivo. The conjugation of a tumor‐homing peptide, LinTT1, on the nanovesicle, increases the efficacy due to enhanced tumor accumulation. Overall, this biomimetic lipid nanocarrier proves to be an efficient delivery system with great potential of pro‐apoptosis cancer therapy.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.